a public good project by the
Synthesis
Company
of California

© 2026

Sandro Feriozzi | doi.page

0 works0 citations0 h-index

Sandro Feriozzi

Università Campus Bio-Medico(IT)Ospedale di Belcolle(IT)Campus Bio Medico University Hospital(IT)

Publications by Year

Research Areas

Lysosomal Storage Disorders Research, Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Trypanosoma species research and implications, Biomedical Research and Pathophysiology

Most-Cited Works

→ Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens(2014)613 cited
→ Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments(2014)489 cited
→ The MEST score provides earlier risk prediction in lgA nephropathy(2015)283 cited
→ Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial(2021)227 cited
→ Contribution of inflammatory pathways to Fabry disease pathogenesis(2017)213 cited
→ Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference(2016)183 cited

→ Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy(2023)

162 cited

→ Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases(2013)142 cited

→ Improvement of Renal Function with Selective Thromboxane Antagonism in Lupus Nephritis(1989)124 cited

→ Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update(2018)107 cited